MiR-33a level has been shown to be negatively correlated with the target gene TWIST and was over-expressed in chemo-resistant osteosarcoma; which resulted in the down-regulation of TWIST, and increased osteosarcoma cell resistance to cisplatin [39]. Here, TWIST1 is linked to osteosarcoma.